Zhen H. Lin
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: a single-arm phase II clinical trial.
Journal: Future oncology (London, England)
Published: July 14, 2026
Correction: Lin et al. Prospects and Challenges of Lung Cancer Vaccines. Vaccines 2025, 13, 836.
Journal: Vaccines
Published: June 04, 2026
Risk factors and prognosis of postoperative early relapse after neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a retrospective study.
Journal: World journal of surgical oncology
Published: May 27, 2025
Different survival and recurrence patterns between neoadjuvant radiochemotherapy and immunochemotherapy in esophageal squamous cell carcinoma.
Journal: Current problems in surgery
Published: September 05, 2024
Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial.
Journal: British journal of cancer
Published: April 29, 2024
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.
Journal: Journal of gastrointestinal oncology
Published: November 12, 2023
A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer.
Journal: Cancer research and treatment
Published: June 06, 2023
Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer.
Journal: Scientific reports
Published: September 24, 2022
Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review.
Journal: Frontiers in oncology
Published: July 29, 2022
Viral infections and the efficacy of PD-(L)1 inhibitors in virus-related cancers: Head and neck squamous cell carcinoma and hepatocellular carcinoma.
Journal: International immunopharmacology
Published: May 13, 2021
Inferior outcome of bone metastasis in non-small-cell-lung-cancer patients treated with epidermal growth factor receptor inhibitors.
Journal: Journal of bone oncology
Published: February 01, 2021
Last Updated: 09/26/2026